Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis

Cirrhosis is an emerging major cause of the development of hepatocellular carcinoma (HCC), but in non-alcoholic fatty liver disease (NAFLD), up to 50% of patients with HCC had no clinical or histological evidence of cirrhosis. It is currently challenging to propose general recommendations for screen...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 29; no. 2; pp. 343 - 356
Main Authors Tovo, Cristiane Valle, de Mattos, Angelo Zambam, Coral, Gabriela Perdomo, Sartori, Giovana D P, Nogueira, Livia Villela, Both, Gustavo Tovo, Villela-Nogueira, Cristiane A, de Mattos, Angelo A
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Inc 14.01.2023
Subjects
Online AccessGet full text
ISSN1007-9327
2219-2840
2219-2840
DOI10.3748/wjg.v29.i2.343

Cover

Abstract Cirrhosis is an emerging major cause of the development of hepatocellular carcinoma (HCC), but in non-alcoholic fatty liver disease (NAFLD), up to 50% of patients with HCC had no clinical or histological evidence of cirrhosis. It is currently challenging to propose general recommendations for screening patients with NAFLD without cirrhosis, and each patient should be evaluated on a case-by-case basis based on the profile of specific risk factors identified. For HCC screening in NAFLD, a valid precision-based screening is needed. Currently, when evaluating this population of patients, the use of non-invasive methods can guide the selection of those who should undergo a screening and surveillance program. Hence, the objective of the present study is to review the epidemiology, the pathophysiology, the histopathological aspects, the current recommendations, and novel perspectives in the surveillance of non-cirrhotic NAFLD-related HCC.
AbstractList Cirrhosis is an emerging major cause of the development of hepatocellular carcinoma (HCC), but in non-alcoholic fatty liver disease (NAFLD), up to 50% of patients with HCC had no clinical or histological evidence of cirrhosis. It is currently challenging to propose general recommendations for screening patients with NAFLD without cirrhosis, and each patient should be evaluated on a case-by-case basis based on the profile of specific risk factors identified. For HCC screening in NAFLD, a valid precision-based screening is needed. Currently, when evaluating this population of patients, the use of non-invasive methods can guide the selection of those who should undergo a screening and surveillance program. Hence, the objective of the present study is to review the epidemiology, the pathophysiology, the histopathological aspects, the current recommendations, and novel perspectives in the surveillance of non-cirrhotic NAFLD-related HCC.
Cirrhosis is an emerging major cause of the development of hepatocellular carcinoma (HCC), but in non-alcoholic fatty liver disease (NAFLD), up to 50% of patients with HCC had no clinical or histological evidence of cirrhosis. It is currently challenging to propose general recommendations for screening patients with NAFLD without cirrhosis, and each patient should be evaluated on a case-by-case basis based on the profile of specific risk factors identified. For HCC screening in NAFLD, a valid precision-based screening is needed. Currently, when evaluating this population of patients, the use of non-invasive methods can guide the selection of those who should undergo a screening and surveillance program. Hence, the objective of the present study is to review the epidemiology, the pathophysiology, the histopathological aspects, the current recommendations, and novel perspectives in the surveillance of non-cirrhotic NAFLD-related HCC.Cirrhosis is an emerging major cause of the development of hepatocellular carcinoma (HCC), but in non-alcoholic fatty liver disease (NAFLD), up to 50% of patients with HCC had no clinical or histological evidence of cirrhosis. It is currently challenging to propose general recommendations for screening patients with NAFLD without cirrhosis, and each patient should be evaluated on a case-by-case basis based on the profile of specific risk factors identified. For HCC screening in NAFLD, a valid precision-based screening is needed. Currently, when evaluating this population of patients, the use of non-invasive methods can guide the selection of those who should undergo a screening and surveillance program. Hence, the objective of the present study is to review the epidemiology, the pathophysiology, the histopathological aspects, the current recommendations, and novel perspectives in the surveillance of non-cirrhotic NAFLD-related HCC.
Author Both, Gustavo Tovo
de Mattos, Angelo A
Villela-Nogueira, Cristiane A
Tovo, Cristiane Valle
Nogueira, Livia Villela
Coral, Gabriela Perdomo
de Mattos, Angelo Zambam
Sartori, Giovana D P
Author_xml – sequence: 1
  givenname: Cristiane Valle
  surname: Tovo
  fullname: Tovo, Cristiane Valle
– sequence: 2
  givenname: Angelo Zambam
  surname: de Mattos
  fullname: de Mattos, Angelo Zambam
– sequence: 3
  givenname: Gabriela Perdomo
  surname: Coral
  fullname: Coral, Gabriela Perdomo
– sequence: 4
  givenname: Giovana D P
  surname: Sartori
  fullname: Sartori, Giovana D P
– sequence: 5
  givenname: Livia Villela
  surname: Nogueira
  fullname: Nogueira, Livia Villela
– sequence: 6
  givenname: Gustavo Tovo
  surname: Both
  fullname: Both, Gustavo Tovo
– sequence: 7
  givenname: Cristiane A
  surname: Villela-Nogueira
  fullname: Villela-Nogueira, Cristiane A
– sequence: 8
  givenname: Angelo A
  surname: de Mattos
  fullname: de Mattos, Angelo A
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36687125$$D View this record in MEDLINE/PubMed
BookMark eNp1kbtPwzAYxC0EgvJYGVFGlgS_EtsLEqp4CSQWmC3HcRpXaVxspxX_Pa5oESAxfcP3uzvp7hjsD24wAJwjWBBG-dV6PitWWBQWF4SSPTDBGIkccwr3wQRByHJBMDsCxyHMIcSElPgQHJGq4gzhcgKeHsxSRadN34-98plWXtvBLVRmhyxl5arXrnO91VmIJpHdhrfRhmxtY-fGmGnrfeeCDafgoFV9MGfbewLe7m5fpw_588v94_TmOde0rGKODG-5qTltm5qLGhGqEaKUtJQRoVvK20bUytSlgAIJCAmnqmWshLxpjMY1OQHXX77LsV6YRpshetXLpbcL5T-kU1b-_gy2kzO3koLTSlCcDC63Bt69jyZEubBhU4EajBuDxKziHGEGq4Re_Mz6Dtk1mAD6BWjvQvCmldrG1JDbRNteIig3Q8k0lExDSYtlGirJij-ynfM_gk86Z5nI
CitedBy_id crossref_primary_10_17925_EE_2023_20_1_1
crossref_primary_10_5493_wjem_v14_i4_98543
crossref_primary_10_62347_SXMJ5155
crossref_primary_10_1016_j_ecoenv_2024_117437
crossref_primary_10_1186_s13046_024_02967_3
crossref_primary_10_17116_onkolog20241306157
crossref_primary_10_3390_ijms25073694
crossref_primary_10_3390_cancers15164097
crossref_primary_10_23736_S0031_0808_23_04850_4
crossref_primary_10_5582_bst_2024_01295
crossref_primary_10_1016_j_jceh_2024_102406
crossref_primary_10_1590_s0004_2803_24612023_151
crossref_primary_10_3390_ijms252413590
crossref_primary_10_3390_cells13231935
crossref_primary_10_1016_j_dsx_2025_103209
crossref_primary_10_1080_17843286_2025_2466011
crossref_primary_10_3390_ijms251810144
crossref_primary_10_3390_cancers16162773
Cites_doi 10.1002/hep.31014
10.1111/jgh.12116
10.1002/hep.30036
10.1002/hep.22734
10.1111/liv.14087
10.1016/j.numecd.2019.06.002
10.1111/liv.13502
10.1016/bs.acr.2020.11.001
10.3748/wjg.v22.i46.10219
10.1016/j.jhep.2017.05.014
10.1053/j.gastro.2018.08.024
10.1056/NEJM199702273360907
10.1002/hep.32542
10.1016/j.jhep.2020.11.024
10.1016/j.jhep.2020.03.039
10.3390/cancers12061422
10.1053/j.gastro.2019.12.053
10.1371/journal.pone.0097136
10.1002/hep.23527
10.1016/S0140-6736(20)30925-9
10.1016/j.jhep.2020.10.016
10.1016/j.jhep.2019.08.016
10.1002/cld.1232
10.1016/j.dld.2021.06.023
10.1002/hep4.1852
10.1053/j.gastro.2020.02.068
10.1002/ijc.30784
10.1016/j.febslet.2010.01.046
10.1016/j.jhep.2016.02.021
10.1016/j.jhep.2016.04.023
10.1016/S0076-6879(08)01420-1
10.1097/TP.0000000000002361
10.1056/NEJMra1713263
10.1016/j.bpg.2016.10.006
10.1136/gut.2009.199661
10.1016/j.cgh.2019.11.012
10.1016/j.humpath.2015.07.018
10.1038/ajg.2011.327
10.1016/j.jhep.2022.01.023
10.1016/j.jhep.2017.09.003
10.1038/s41467-020-20422-7
10.1016/j.cgh.2020.04.019
10.1016/j.semcancer.2017.06.005
10.1093/aje/kwt335
10.3748/wjg.v21.i4.1189
10.1038/ajg.2016.330
10.1038/s41575-019-0145-7
10.1038/s41598-017-04991-0
10.1007/s10620-016-4085-6
10.21037/hbsn.2019.08.08
10.3390/cancers13225844
10.4254/wjh.v14.i2.354
10.1016/j.cgh.2021.05.002
10.14740/gr1110
10.1002/hep.31288
10.1002/hep.29367
10.1093/ije/dyaa196
10.1038/s41575-020-00381-6
10.1016/S0140-6736(14)60892-8
10.1136/gutjnl-2017-315084
10.1038/nmat4997
10.1053/j.gastro.2022.06.023
10.1007/s12072-015-9679-0
10.1016/j.jhep.2022.06.012
10.1186/s12916-019-1321-x
10.1016/j.ccr.2014.07.001
10.1002/cam4.1078
10.1016/j.jhep.2018.03.019
10.1111/apt.14937
10.4254/wjh.v13.i9.1107
10.5152/tjg.2021.20677
10.1002/hep.30858
10.1002/hep.28368
10.1111/jgh.14867
10.3390/biomedicines9101359
10.3748/wjg.v20.i7.1768
10.1016/j.humpath.2011.07.005
10.1016/j.jhep.2021.08.012
10.1038/nature13478
10.1111/jebm.12270
10.1038/s41374-020-00493-2
10.3390/cancers12102778
10.4254/wjh.v11.i1.1
10.1111/hepr.13203
10.1016/j.jhep.2021.05.008
10.1038/ajg.2013.476
10.1007/s00204-008-0304-z
10.1158/2159-8290.CD-16-0932
10.1002/hep.28431
10.1097/MEG.0000000000000480
10.1016/j.cgh.2015.12.042
ContentType Journal Article
Copyright The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. 2023
Copyright_xml – notice: The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
– notice: The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. 2023
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.3748/wjg.v29.i2.343
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Tovo CV et al. Non-cirrhotic NAFLD related HCC
EISSN 2219-2840
EndPage 356
ExternalDocumentID PMC9846942
36687125
10_3748_wjg_v29_i2_343
Genre Journal Article
Review
GroupedDBID ---
123
29R
2WC
36B
53G
5VR
8WL
AAKDD
AAYXX
ACGFO
AENEX
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CHBEP
CIEJG
CITATION
CS3
CW9
DIK
DU5
E3Z
EBS
EJD
F5P
FA0
FRP
GX1
HYE
OK1
P2P
RNS
RPM
TR2
XSB
CGR
CUY
CVF
ECM
EIF
M~E
NPM
7X8
5PM
ID FETCH-LOGICAL-c456t-1e8f8eb84fdb89b134c11443f4739cf48fd9baeb59091900384af77508ddec2b3
ISSN 1007-9327
2219-2840
IngestDate Thu Aug 21 18:39:13 EDT 2025
Thu Jul 10 17:21:32 EDT 2025
Thu Jan 02 22:55:28 EST 2025
Tue Jul 01 02:11:56 EDT 2025
Thu Apr 24 23:07:15 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 2
Keywords Obesity
Hepatocellular carcinoma
Microbiota
Genetic variants
Non-alcoholic fatty liver disease
Non-alcoholic steatohepatitis
Language English
License The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c456t-1e8f8eb84fdb89b134c11443f4739cf48fd9baeb59091900384af77508ddec2b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Corresponding author: Cristiane Valle Tovo, MD, PhD, Associate Professor, Internal Medicine, Universidade Federal de Ciências da Saúde de Porto Alegre, Rua Sarmento Leite 245, Porto Alegre 90050170, RS, Brazil. cris.tovo@terra.com.br
Author contributions: Tovo CV and de Mattos AA conceptualized the study; all authors contributed equally to drafting the article and making critical revisions related to important intellectual content of the manuscript; and all authors approved the final version of the article to be published.
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC9846942
PMID 36687125
PQID 2768812706
PQPubID 23479
PageCount 14
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9846942
proquest_miscellaneous_2768812706
pubmed_primary_36687125
crossref_citationtrail_10_3748_wjg_v29_i2_343
crossref_primary_10_3748_wjg_v29_i2_343
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-1-14
2023-Jan-14
20230114
PublicationDateYYYYMMDD 2023-01-14
PublicationDate_xml – month: 01
  year: 2023
  text: 2023-1-14
  day: 14
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle World journal of gastroenterology : WJG
PublicationTitleAlternate World J Gastroenterol
PublicationYear 2023
Publisher Baishideng Publishing Group Inc
Publisher_xml – name: Baishideng Publishing Group Inc
References B20
B64
B21
B65
B22
B66
B23
B67
B24
B68
B25
B69
B26
B27
B28
B29
B70
B71
B72
B73
B30
B74
B31
B75
B32
B76
B33
B77
B34
B78
B35
B79
B36
B37
B38
B39
B1
B2
B3
B4
B5
B6
B7
B8
B9
B80
B81
B82
B83
B40
B84
B41
B85
B42
B86
B43
B87
B44
B88
B45
B89
B46
B47
B48
B49
B90
B91
B92
B93
B50
B94
B51
B52
B53
B10
B54
B11
B55
B12
B56
B13
B57
B14
B58
B15
B59
B16
B17
B18
B19
B60
B61
B62
B63
References_xml – ident: B12
– ident: B57
  doi: 10.1002/hep.31014
– ident: B72
  doi: 10.1111/jgh.12116
– ident: B51
  doi: 10.1002/hep.30036
– ident: B69
  doi: 10.1002/hep.22734
– ident: B59
  doi: 10.1111/liv.14087
– ident: B32
  doi: 10.1016/j.numecd.2019.06.002
– ident: B17
  doi: 10.1111/liv.13502
– ident: B25
  doi: 10.1016/bs.acr.2020.11.001
– ident: B80
  doi: 10.3748/wjg.v22.i46.10219
– ident: B76
  doi: 10.1016/j.jhep.2017.05.014
– ident: B27
  doi: 10.1053/j.gastro.2018.08.024
– ident: B38
  doi: 10.1056/NEJM199702273360907
– ident: B58
  doi: 10.1002/hep.32542
– ident: B87
  doi: 10.1016/j.jhep.2020.11.024
– ident: B2
  doi: 10.1016/j.jhep.2020.03.039
– ident: B23
  doi: 10.3390/cancers12061422
– ident: B85
  doi: 10.1053/j.gastro.2019.12.053
– ident: B37
  doi: 10.1371/journal.pone.0097136
– ident: B64
  doi: 10.1002/hep.23527
– ident: B16
  doi: 10.1016/S0140-6736(20)30925-9
– ident: B63
  doi: 10.1016/j.jhep.2020.10.016
– ident: B53
  doi: 10.1016/j.jhep.2019.08.016
– ident: B88
  doi: 10.1002/cld.1232
– ident: B29
  doi: 10.1016/j.dld.2021.06.023
– ident: B40
– ident: B93
  doi: 10.1002/hep4.1852
– ident: B11
  doi: 10.1053/j.gastro.2020.02.068
– ident: B65
  doi: 10.1002/ijc.30784
– ident: B42
  doi: 10.1016/j.febslet.2010.01.046
– ident: B19
  doi: 10.1016/j.jhep.2016.02.021
– ident: B94
  doi: 10.1016/j.jhep.2016.04.023
– ident: B44
  doi: 10.1016/S0076-6879(08)01420-1
– ident: B81
  doi: 10.1097/TP.0000000000002361
– ident: B21
  doi: 10.1056/NEJMra1713263
– ident: B77
  doi: 10.1016/j.bpg.2016.10.006
– ident: B48
  doi: 10.1136/gut.2009.199661
– ident: B91
  doi: 10.1016/j.cgh.2019.11.012
– ident: B74
  doi: 10.1016/j.humpath.2015.07.018
– ident: B68
  doi: 10.1038/ajg.2011.327
– ident: B78
  doi: 10.1016/j.jhep.2022.01.023
– ident: B30
  doi: 10.1016/j.jhep.2017.09.003
– ident: B50
  doi: 10.1038/s41467-020-20422-7
– ident: B62
  doi: 10.1016/j.cgh.2020.04.019
– ident: B39
  doi: 10.1016/j.semcancer.2017.06.005
– ident: B66
  doi: 10.1093/aje/kwt335
– ident: B4
  doi: 10.3748/wjg.v21.i4.1189
– ident: B8
  doi: 10.1038/ajg.2016.330
– ident: B15
  doi: 10.1038/s41575-019-0145-7
– ident: B34
  doi: 10.1038/s41598-017-04991-0
– ident: B7
  doi: 10.1007/s10620-016-4085-6
– ident: B20
  doi: 10.21037/hbsn.2019.08.08
– ident: B41
  doi: 10.3390/cancers13225844
– ident: B55
  doi: 10.4254/wjh.v14.i2.354
– ident: B28
  doi: 10.1016/j.cgh.2021.05.002
– ident: B73
  doi: 10.14740/gr1110
– ident: B10
  doi: 10.1002/hep.31288
– ident: B1
  doi: 10.1002/hep.29367
– ident: B13
  doi: 10.1093/ije/dyaa196
– ident: B56
  doi: 10.1038/s41575-020-00381-6
– ident: B60
  doi: 10.1016/S0140-6736(14)60892-8
– ident: B52
  doi: 10.1136/gutjnl-2017-315084
– ident: B89
  doi: 10.1038/nmat4997
– ident: B3
  doi: 10.1053/j.gastro.2022.06.023
– ident: B5
  doi: 10.1007/s12072-015-9679-0
– ident: B18
– ident: B49
  doi: 10.1016/j.jhep.2022.06.012
– ident: B22
  doi: 10.1186/s12916-019-1321-x
– ident: B46
  doi: 10.1016/j.ccr.2014.07.001
– ident: B36
  doi: 10.1002/cam4.1078
– ident: B84
  doi: 10.1016/j.jhep.2018.03.019
– ident: B9
  doi: 10.1111/apt.14937
– ident: B26
  doi: 10.4254/wjh.v13.i9.1107
– ident: B71
  doi: 10.5152/tjg.2021.20677
– ident: B61
  doi: 10.1002/hep.30858
– ident: B6
  doi: 10.1002/hep.28368
– ident: B24
  doi: 10.1111/jgh.14867
– ident: B31
  doi: 10.3390/biomedicines9101359
– ident: B45
  doi: 10.3748/wjg.v20.i7.1768
– ident: B75
  doi: 10.1016/j.humpath.2011.07.005
– ident: B86
  doi: 10.1016/j.jhep.2021.08.012
– ident: B43
  doi: 10.1038/nature13478
– ident: B67
  doi: 10.1111/jebm.12270
– ident: B35
  doi: 10.1038/s41374-020-00493-2
– ident: B92
  doi: 10.3390/cancers12102778
– ident: B82
  doi: 10.4254/wjh.v11.i1.1
– ident: B70
  doi: 10.1111/hepr.13203
– ident: B83
  doi: 10.1016/j.jhep.2021.05.008
– ident: B33
  doi: 10.1038/ajg.2013.476
– ident: B47
  doi: 10.1007/s00204-008-0304-z
– ident: B54
  doi: 10.1158/2159-8290.CD-16-0932
– ident: B14
  doi: 10.1002/hep.28431
– ident: B79
  doi: 10.1097/MEG.0000000000000480
– ident: B90
  doi: 10.1016/j.cgh.2015.12.042
SSID ssj0023352
Score 2.4747736
SecondaryResourceType review_article
Snippet Cirrhosis is an emerging major cause of the development of hepatocellular carcinoma (HCC), but in non-alcoholic fatty liver disease (NAFLD), up to 50% of...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 343
SubjectTerms Carcinoma, Hepatocellular - diagnosis
Carcinoma, Hepatocellular - epidemiology
Carcinoma, Hepatocellular - etiology
Fibrosis
Humans
Liver Cirrhosis - complications
Liver Cirrhosis - diagnosis
Liver Cirrhosis - epidemiology
Liver Neoplasms - diagnosis
Liver Neoplasms - epidemiology
Liver Neoplasms - etiology
Minireviews
Non-alcoholic Fatty Liver Disease - complications
Non-alcoholic Fatty Liver Disease - diagnosis
Non-alcoholic Fatty Liver Disease - epidemiology
Risk Factors
Title Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
URI https://www.ncbi.nlm.nih.gov/pubmed/36687125
https://www.proquest.com/docview/2768812706
https://pubmed.ncbi.nlm.nih.gov/PMC9846942
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELaq5cIFgXiVl4KExKFyafO0j8vyqBYt4tCFFZfIduw2aBujNl0kfhS_kZnYzSZdkGAvUZU4Vjoz8cx8GX9DyAudpJHhLKHFdGIoxLch5Qrp8aZcpqEO2UQiDnnyMZ2dxsdnydlg8KtTtbSt5Vj9_OO-kutoFc6BXnGX7H9otp0UTsBv0C8cQcNw_Ccdz8CX1Bax96aYVGFfoMquBIIYkNZT4frflmqEuqztEscjiVEDv2JFsirX66XdlJtukOoKbDqcEguxqdcW2TvXjrIJcYQvx21brrm9cIirXzH06DO2aNldLrC_UV27gr5DrKK1o69iJcWq_QKCPAENRC8k5O7nAivzC7uyLQAE_966TfHvsXy2EqM3fmuahyxCLNii00vI8jU2lsaWqYsrWFu_-hMrOCgEmM4j6-ZcCEssBZ866S7hHjQpO5m0W48jxwHlXXvkOMz3vQYy8ICqf3xbjC9CPi7DcXtbj4n708kRh3CNx-Dyb4QZxGo7dMgn-Lh_rfm67h_bkYTi9K_6k_eDoCuZzX6Bbifimd8mt3yqEhw6u7tDBrq6Sz70bS5obS4oq6Bnc8GezQXe5oLW5u6R03dv50cz6htyUAVxdk2nmhmmJYtNIRmX0yhWkE7HkYmziCsTM1NwKbRMOEShCJGzWJgMYlIGTlSFMrpPDuBJ9EMSTOLMGFg9hCqKWKWJUIkRE60TU2gutB4SupNQrjxbPTZNOc8ha0WJ5iDRHCSal2EOEh2Sl-34746n5a8jn-8EnsNSivKC98JuNzmolDGsxEiH5IFTQDtXlKYsg2RgSLKeatoBSNPev1KVy4au3dvMo2vf-ZjcvHyLnpCDer3VTyEUruWzxv5-Axs5wgQ
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hepatocellular+carcinoma+in+non-alcoholic+steatohepatitis+without+cirrhosis&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Tovo%2C+Cristiane+Valle&rft.au=de+Mattos%2C+Angelo+Zambam&rft.au=Coral%2C+Gabriela+Perdomo&rft.au=Sartori%2C+Giovana+D+P&rft.date=2023-01-14&rft.pub=Baishideng+Publishing+Group+Inc&rft.issn=1007-9327&rft.eissn=2219-2840&rft.volume=29&rft.issue=2&rft.spage=343&rft.epage=356&rft_id=info:doi/10.3748%2Fwjg.v29.i2.343&rft.externalDocID=PMC9846942
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1007-9327&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1007-9327&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1007-9327&client=summon